A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation

Journal of Molecular Endocrinology

Volumn 38, Issue 1-2, 2007, Pages 259-275

  Nurwakagari, Pascal ^a   Breit, Andreas ^a   Hess, Claudia ^a   Salman Livny, Hagar ^b   Ben Menahem, David ^b   Gudermann, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; CYCLIC AMP; HYBRID PROTEIN; LUTEINIZING HORMONE RECEPTOR; THYROTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; HORMONE BINDING; HORMONE RECEPTOR INTERACTION; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR INTRINSIC ACTIVITY; SITE DIRECTED MUTAGENESIS;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; LUTEINIZING HORMONE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, LH;

EID: 33847644034     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.02160     Document Type: Article

References (51)

1. Alvarez CA, Narayan P, Huang J & Puett D 1999 Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling. Endocrinology 140 1775-1782.
2. Ascoli M, Fanelli F & Segaloff DL 2002 The lutropin /choriogonadotropin receptor, a 2002 perspective. Endocrine Reviews 23 141-174.
3. Ben-Menahem D 2004 Single chain variants of the glycoprotein hormones and their receptors as tools to study receptor activation and for analogue design. Journal of Neuroendocrinology 16 171-177.
4. Bhowmick N, Huang J, Puett D, Isaacs NW & Lapthorn AJ 1996 Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Molecular Endocrinology 10 1147-1159.
5. Biebermann H, Schoneberg T, Krude H, Schultz G, Gudermann T & Gruters A 1997 Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. Journal of Clinical Endocrinology and Metabolism 82 3471-3480.
6. Biebermann H, Schoneberg T, Schulz A, Krause G, Gruters A, Schultz G & Gudermann T 1998 A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling. FASEB Journal 12 1461-1471.
7. Braun T, Schofield PR & Sprengel R 1991 Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO Journal 10 1885-1890.
8. Cetani F, Tonacchera M & Vassart G 1996 Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors. FEBS Letters 378 27-31.
9. Couture L, Remy JJ, Rabesona H, Troalen F, Pajot-Augy E, Bozon V, Haertle T, Bidart JM & Salesse R 1996 A defined epitope on the human choriogonadotropin alpha-subunit interacts with the second extracellular loop of the transmembrane domain of the lutropin/choriogonadotropin receptor. European Journal of Biochemistry 241 627-632.
10. Fan QR & Hendrickson WA 2005 Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433 269-277.
11. Garcia-Campayo V, Kumar TR & Boime I 2002 Thyrotropin, follitropin, and chorionic gonadotropin expressed as a single multifunctional unit reveal remarkable permissiveness in receptor-ligand interactions. Endocrinology 143 3773-3778.
12. Garcia-Campayo V, Jablonka-Shariff A & Boime I 2004 A single-chain bifunctional gonadotropin analog is secreted from Chinese hamster ovary cells as two distinct bioactive species. Journal of Biological Chemistry 279 44286-44293.
13. Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H & Gudermann T 1998 Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. Journal of Clinical Endocrinology and Metabolism 83 1431-1436
14. 2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. Journal of Biological Chemistry 267 4479-4488.
15. Herpin A, Badariotti F, Rodet F & Favrel P 2004 Molecular characterization of a new leucine-rich repeat-containing G protein-coupled receptor from a bivalve mollusc: evolutionary implications. Biochimica et Biophysica Acta 1680 137-144.
16. Hong S, Phang T, Ji I & Ji TH 1998 The amino-terminal region of the luteinizing hormone/choriogonadotropin receptor contacts both subunits of human choriogonadotropin. I. Mutational analysis. Journal of Biological Chemistry 273 13835-13840.
17. Hong S, Ji I & Ji TH 1999a The alpha-subunit of human choriogonadotropin interacts with the exodomain of the luteinizing hormone/ choriogonadotropin receptor. Endocrinology 140 2486-2493.
18. Hong SH, Ji IH & Ji TH 1999b The beta-subunit of human choriogonadotropin interacts with the exodomain of the luteinizing hormone/choriogonadotropin receptor and changes its interaction with the alpha-subunit. Molecular Endocrinology 13 1285-1294.
19. Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, van Duin M & Hsueh AJ 2000 The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Molecular Endocrinology 14 1257-1271.
20. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD & Hsueh AJ 2002 Activation of orphan receptors by the hormone relaxin. Science 295 671-674.
21. Ji IH & Ji TH 1991 Human choriogonadotropin binds to a lutropin receptor with essentially no N-terminal extension and stimulates cAMP synthesis. Journal of Biological Chemistry 266 13076-13079.
22. Karges B, Gidenne S, Aumas C, Haddad F, Kelly PA, Milgrom E & de Roux N 2005 Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the LH receptor persist during receptor activation. Molecular Endocrinology 19 2086-2098.
23. Kosugi S, Mori T & Shenker A 1996 The role of Asp578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. Journal of Biological Chemistry 271 31813-31817.
24. Kremer H, Martens JW, van Reen M, Verhoef-Post M, Wit JM, Otten BJ, Drop SL, Delemarre-van de Waal HA, Pombo-Arias M, De Luca F et al. 1999 A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. Journal of Clinical Endocrinology and Metabolism 84 1136-1140.
25. Kundu GC, Ji I, McCormick DJ & Ji TH 1996 Photoaffinity labeling of the lutropin receptor with synthetic peptide for carboxyl terminus of the human choriogonadotropin alpha subunit. Journal of Biological Chemistry 271 11063-11066.
26. Latronico AC, Abell AN, Arnhold IJ, Liu X, Lins TS, Brito VN, Billerbeck AE, Segaloff DL & Mendonca BB 1998 A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. Journal of Clinical Endocrinology and Metabolism 83 2435-2440.
27. Laue L, Chan WY, Hsueh AJ, Kudo M, Hsu SY, Wu SM, Blomberg L & Cutler GB Jr 1995 Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. PNAS 92 1906-1910.
28. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA & Shenker A 1999 Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. New England Journal of Medicine 341 1731-1736.
29. Moyle WR, Campbell PK, Myers RV, Bernard MP, Han Y & Wang X 1994 Co-evolution of ligand-receptor pairs. Nature 368 251-255.
30. Muller J, Gondos B, Kosugi S, Mori T & Shenker A 1998 Severe testotoxicosis phenotype associated with Asp578 → Tyr mutation of the lutrophin/choriogonadotrophin receptor gene. Journal of Medical Genetics 35 340-341.
31. Nakabayashi K, Kudo M, Kobilka B & Hsueh AJ 2000 Activation of the luteinizing hormone receptor following substitution of Ser-277 with selective hydrophobic residues in the ectodomain hinge region. Journal of Biological Chemistry 275 30264-30271.
32. Narayan P, Gray J & Puett D 2000 A biologically active single chain human chorionic gonadotropin analog with altered receptor binding properties. Endocrinology 141 67-71.
33. Narayan P, Gray J & Puett D 2002 Yoked complexes of human choriogonadotropin and the lutropin receptor: evidence that monomeric individual subunits are inactive. Molecular Endocrinology 16 2733-2745.
34. Nishi S, Nakabayashi K, Kobilka B & Hsuch AJ 2002 The ectodomain of the luteinizing hormone receptor interacts with exoloop 2 to constrain the transmembrane region: studies using chimeric human and fly receptors. Journal of Biological Chemistry 277 3958-3964.
35. Phang T, Kundu G, Hong S, Ji I & Ji TH 1998 The amino-terminal region of the luteinizing hormone/choriogonadotropin receptor contacts both subunits of human choriogonadotropin. II. Photoaffinity labeling. Journal of Biological Chemistry 273 13841-13847.
36. Rapoport B, Chazenbalk GD, Jaume JC & McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocrine Reviews 19 673-716.
37. Salomon Y, Londos C & Rodbell M 1974 A highly sensitive adenylate cyclase assay. Analytical Biochemistry 58 541-548.
38. Sangkuhl K, Schulz A, Schultz G & Schoneberg T 2002 Structural requirements for mutational lutropin/choriogonadotropin receptor activation. Journal of Biological Chemistry 277 47748-47755.
39. Schoneberg T, Sandig V, Wess J, Gudermann T & Schultz G 1997 Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. Journal of Clinical Investigation 100 1547-1556.
40. Schulz A, Schoneberg T, Paschke R, Schultz G & Gudermann T 1999 Role of the third intracellular loop for the activation of gonadotropin receptors. Molecular Endocrinology 13 181-190.
41. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L & Costagliola S 2003 Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO Journal 22 2692-2703.
42. Sugahara T, Pixley MR, Minami S, Perlas E, Ben-Menahem D, Hsueh AJ & Boime I 1995 Biosynthesis of a biologically active single peptide chain containing the human common alpha and chorionic gonadotropin beta subunits in tandem. PNAS 92 2041-2045.
43. Thomas D, Rozell TG, Liu X & Segaloff DL 1996 Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadortropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding. Molecular Endocrinology 10 760-768.
44. Van Sande J, Massart C, Costagliola S, Allgeier A, Cetani F, Vassart G & Dumont JE 1996 Specific activation of the thyrotropin receptor by trysin. Molecular and Cellular Endocrinology 119 161-168.
45. Vassart G, Pardo L & Costagliola S 2004 A molecular dissection of the glycoprotein hormone receptors. Trends in Biochemical Sciences 29 119-126.
46. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G & Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Molecular Endocrinology 16 736-746.
47. Xie YB, Wang H & Segaloff DL 1990 Extracellular domain of lutropin/ choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. Journal of Biological Chemistry 265 21411-21414.
48. Yano K, Kohn LD, Saji M, Kataoka N, Okuno A & Cutler GB Jr 1996 A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene. Biochemical and Biophysical Research Communications 220 1036-1042.
49. Zhang ML, Sugawa H, Kosugi S & Mori T 1995 Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochemical and Biophysical Research Communications 211 205-210.
50. Zhang M, Tong KP, Fremont V, Chen J, Narayan P, Puett D, Weintraub BD & Szkudlinski MW 2000 The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 141 3514-3517.
51. Zhang M, Mizrachi D, Fanelli F & Segaloff DL 2005 The formation of a salt bridge between helices 3 and 6 is responsible for the constitutive activity and lack of hormone responsiveness of the naturally occurring L457R mutation of the human lutropin receptor. Journal of Biological Chemistry 280 26169-26176.